Targeted transgene expression in rat brain using lentiviral vectors

Journal of Neuroscience Research

Volumn 73, Issue 6, 2003, Pages 876-885

  Jakobsson, Johan ^a   Ericson, Cecilia ^a   Jansson, Maria ^a   Björk, Elin ^a   Lundberg, Cecilia ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Cell specific; Glia; Lentiviral vectors; Neuron; Pseudotype

Indexed keywords

ELONGATION FACTOR 1ALPHA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LENTIVIRUS VECTOR; NEURON SPECIFIC ENOLASE; VIRUS PROTEIN;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; CORPUS STRIATUM; FEMALE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GLIA CELL; HUMAN; HUMAN CYTOMEGALOVIRUS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; TRANSGENE; VESICULAR STOMATITIS VIRUS;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS; BRAIN; CELL COUNT; CELL LINE; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; LUMINESCENT PROTEINS; MEMBRANE GLYCOPROTEINS; PEPTIDE ELONGATION FACTOR 1; PHOSPHOPYRUVATE HYDRATASE; PROMOTER REGIONS (GENETICS); PROTEOGLYCANS; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES; UBIQUITINS; VIRAL ENVELOPE PROTEINS;

EID: 0041336901     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10719     Document Type: Article

References (33)

1. Blomer U, Naldini L, Kafri T, et al. 1997. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J Virol 71:6641-6649.
2. Brenner M, Kisseberth WC, Su Y, et al. 1994. GFAP promoter directs astrocyte-specific expression in transgenic mice. J Neurosci 14:1030-1037.
3. de Almeida LP, Ross CA, Zala D, et al. 2002. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. J Neurosci 22:3473-3483.
4. Deglon N, Tseng JL, Bensadoun JC, et al. 2000. Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum Gene Ther 11:179-190.
5. Desmaris N, Bosch A, Salaun C, et al. 2001. Production and neurotropism of lentivirus vectors pseudotyped with Lyssavirus envelope glycoproteins. Mol Ther 4:149-156.
6. Englund U, Fricker-Gates RA, Lundberg C, et al. 2002. Transplantation of human neural progenitor cells into the neonatal rat brain: extensive migration and differentiation with long-distance axonal projections. Exp Neurol 173:1-21.
7. Ericson C, Wictorin K, Lundberg C. 2002. Ex vivo and in vitro studies of transgene expression in rat astrocytes transduced with lentiviral vectors. Exp Neurol 173:22-30.
8. Follenzi A, Ailles LE, Bakovic S, et al. 2000. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 Pol sequences. Nat Genet 25:217-222.
9. Forss-Petter S, Danielson PE, Catsicas S, et al. 1990. Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control. Neuron 5:187-197.
10. Georgievska B, Kirik D, Bjorklund A. 2002a. Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp Neurol 177:461-474.
11. Georgievska B, Kirik D, Rosenblad C, et al. 2002b. Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector. Neuroreport 13:75-82.
12. Kang Y, Stein CS, Heth JA, et al. 2002. In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol 76:9378-9388.
13. Kordower JH, Bloch J, Ma SY, et al. 1999. Lentiviral gene transfer to the nonhuman primate brain. Exp Neurol 160:1-16.
14. Kordower JH, Emborg ME, Bloch J, et al. 2000. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 290:767-773.
15. Lo Bianco C, Ridet JL, Schneider BL, et al. 2002. α -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease. Proc Natl Acad Sci USA 99:10813-10818.
16. Mazarakis ND, Azzouz M, Rohll JB, et al. 2001. Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum Mol Genet 10:2109-2121.
17. Miura M, Tamura T, Mikoshiba K. 1990. Cell-specific expression of the mouse glial fibrillary acidic protein gene: identification of the cis- and trans-acting promoter elements for astrocyte-specific expression. J Neurochem 55:1180-1188.
18. Mizushima S, Nagata S. 1990. pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 18:5322.
19. Naldini L, Blomer U, Gage FH, et al. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 93:11382-11388.
20. Naldini L, Verma IM. 2000. Lentiviral vectors. Adv Virus Res 55:599-609.
21. Nikkhah G, Cunningham MG, Cenci MA, et al. 1995. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J Neurosci 15:3548-3561.
22. Niwa H, Yamamura K, Miyazaki J. 1991. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
23. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
24. Pikaart MJ, Recillas-Targa F, Felsenfeld G. 1998. Loss of transcriptional activity of a transgene is accompanied by DNA methylation and histone deacetylation and is prevented by insulators. Genes Dev 12:2852-2862.
25. Ramezani A, Hawley TS, Hawley RG. 2000. Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol Ther 2:458-469.
26. Regulier E, Pereira de Almeida L, Sommer B, et al. 2002. Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease. Hum Gene Ther 13:1981-1990.
27. Sanders DA. 2002. No false start for novel pseudotyped vectors. Curr Opin Biotechnol 13:437-442.
28. Stromberg I, Bjorklund H, Dahl D, et al. 1986. Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry. Brain Res Bull 17:225-236.
29. Trono D. 2000. Lentiviral vectors: turning a deadly foe into a therapeutic agent. Gene Ther 7:20-23.
30. von Schwedler U, Song J, Aiken C, et al. 1993. Vif is crucial for human immunodeficiency virus type 1 proviral DNA synthesis in infected cells. J Virol 67:4945-4955.
31. West MJ, Slomianka L, Gundersen HJ. 1991. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 231:482-497.
32. Zufferey R, Donello JE, Trono D, et al. 1999. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J Virol 73:2886-2892.
33. Zufferey R, Nagy D, Mandel RJ, et al. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 15:871-875.